SKG Pharma is a licensed GMP manufacturing organization based in Lagos, Nigeria. The Company is one of the major players in a diverse and competitive market
SKG-Pharma Ltd started business in Nigeria in the year 1962, as LePetit Ltd. This company became Wellcome Le Petit Ltd and transformed to Wellcome Nig Ltd when it became a full subsidiary of Wellcome Plc, UK. The company Wellcome Nig. Ltd became established as one of the leading pharmaceutical companies in Nigeria with a fully equipped fac tory that manufactured many of the Wellcome brands.
In 1994, the Rumon Organisation UK, bought the majority shareholding of Wellcome UK. This gave rise to SKG-Pharma Ltd, which continued to manufacture the Wellcome brands in Nigeria under licence and represent Wellcome UK for the non-locally manufactured brands on an agency basis until the year 2000. Following the takeover of Wellcome by Glaxo, the relationship that SKG-Pharma had with Wellcome UK was affected as GlaxoWellcome’s operation in Nigeria naturally took up the former Wellcome brands.
SKG-Pharma has continued to operate in the main with own brands (some of which are replacements for the former Wellcome brands) and some imported brands.
SKG Pharma has over the years maintain a powerful, ethical and respected pharmaceutical brand in the West Africa market place over 50 years of its existence the company has built strong marketing relationships with all the key players through a dedicated sales force with elf and overseas manufactured product.
To be most admired pharmaceutical company in Nigeria.
To create in every aspect of our business-superior value by use of continuous improvement to exceed customer expectations.
Odu’a Investment Company Limited own 0.7% shares in this company while 99.3% of the share are own by other investors.